
Kaskela Law is investigating Humana Inc. for potential breach of fiduciary duty related to alleged false and misleading statements about its Medicare Advantage business made between July 2022 and October 2024. The investigation follows a federal securities fraud complaint claiming Humana's executives misled investors, causing stock price declines starting mid-2023. The law firm encourages long-term shareholders to contact them for legal options. This case could impact Humana's governance and shareholder value moving forward.